With drugmakers facing incredible pressures to get drugs to market quickly, safely and affordably, every addition to development and manufacturing efficiencies matters
In our three-part series, we cover the trajectory of cancer-fighting ADCs in the pharma industry, including the modality’s history, obstacles and success stories
This three-part series will dig into incretin mimetics, their rise to fame in weight management and what it will take for the drug class to truly transform obesity care
In this initial installment of our exploration into the history and evolution of oral solid dose drugs, we take a look at the transformative path from ancient pills to the future...
The collab will give AstraZeneca access to Absci's generative AI platform with the goal of accelerating the discovery of a potential new cancer treatment
Discover five steps required to help create a compelling business case and get the key facts and figures you need to achieve senior buy-in for a digitalized QC Platform.
The pharma industry is under pressure to speed new drugs to market, lower manufacturing costs and expand into new markets — and they are looking for partners who can help. CDMOs...
Challenges can arise when transitioning a media formulation from a non-cGMP prototype to a cGMP-manufactured product. Our case study outlines the scale-up process that was used...
Considering scalability, cost effectiveness, and convenience is essential to find a media format that can meet your current and future needs. Read our article to learn more about...
Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success